ADHERENCE TO PRESCRIBED DOSES OF ABT-450/R/OMBITASVIR, DASABUVIR, AND RIBAVIRIN IN THE PHASE 3 PEARL-II, PEARL-III, AND PEARL-IV TRIALS

David E. Bernstein  1     Rui Tato Marinho  2     Daniel E. Cohen  3     Fritz Bredeek  4     Ferenc Schneider  5     Gunnar Norkrans  6     Manuela Curescu     Michael Bennett     Marina Maevskaya     Jeffrey Fessel     Yan Luo     Jeffrey Enejosa    
1 Hofstra North Shore- Lij School Of Medicine, Manhasset, United States
2 Centro Hospitalar Lisboa Norte, Medical School Of Lisbon, Lisbon, Portugal
3 Abbvie Inc., North Chicago, United States
4 Metropolis Medical Group, San Francisco, United States
5 Markusovszky Hospital, Szombathely, Hungary
6 Sahlgrenska University Hospital, Göteborg, S

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing